17 november, 2016
Cancer is the leading cause of death in Sub-Saharan Africa. Over the next five years, the annual number of new cases is predicted to increase to one million1. From today Partners for Cancer Diagnosis and Treatment in Africa provide access to rapid cancer diagnostics for three million civilians in Rwanda.
The National Cancer Institute (NCI), the National Institutes of Health (NIH), American Society for Clinical Pathology (ASCP), Sakura Finetek and other partners have announced the opening of a state of the art histopathology laboratory in Butaro, Rwanda. Providing patients in resource limited areas of Rwanda with access to rapid cancer diagnostics and appropriate care and treatment.